efzimfotase alfa - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Muscatine mass shooting leaves six dead before gunman dies by suicide

Can Toms Capital force McCormick to defend its Unilever food deal more aggressively?

Representative image of India and Myanmar flags on a diplomatic meeting table as Narendra Modi and U Min Aung Hlaing discuss border security, Northeast stability, trade, connectivity and assurances that Myanmar territory will not be used against India.

Myanmar assures India on security concerns as Modi meeting puts Northeast border stability in focus

Tega Industries completes $1.5bn Molycop acquisition with Apollo Funds as TEGA scales global mining consumables platform

Representative image of pharmaceutical research, drug pipeline analytics and commercial growth trends, reflecting AstraZeneca’s Q1 2026 results and its push to sustain oncology, rare disease and respiratory medicine momentum toward its 2030 revenue ambition.

Read More

Pharma Industry News

AstraZeneca Q1 2026 results: Can oncology and rare disease growth keep AZN’s 2030 ambition on track?

AstraZeneca’s growth engine is firing, but pricing pressure and launch risk still loom. Can oncology and rare disease carry AZN to 2030?

April 29, 2026

web analytics